NASDAQ:GEVO Gevo (GEVO) Stock Price, News & Analysis $0.61 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$0.60▼$0.6350-Day Range$0.54▼$0.7152-Week Range$0.53▼$1.73Volume735,507 shsAverage Volume5.14 million shsMarket Capitalization$143.20 millionP/E RatioN/ADividend YieldN/APrice Target$4.76 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Gevo alerts: Email Address Gevo MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside685.6% Upside$4.76 Price TargetShort InterestHealthy10.68% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.57Based on 5 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.34) to ($0.32) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.27 out of 5 starsOils/Energy Sector170th out of 248 stocksIndustrial Organic Chemicals Industry15th out of 17 stocks 3.3 Analyst's Opinion Consensus RatingGevo has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageGevo has only been the subject of 1 research reports in the past 90 days.Read more about Gevo's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted10.68% of the outstanding shares of Gevo have been sold short.Short Interest Ratio / Days to CoverGevo has a short interest ratio ("days to cover") of 6.9.Change versus previous monthShort interest in Gevo has recently decreased by 21.05%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldGevo does not currently pay a dividend.Dividend GrowthGevo does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for GEVO. Previous Next 3.1 News and Social Media Coverage News SentimentGevo has a news sentiment score of 0.57. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Oils/Energy companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Gevo this week, compared to 2 articles on an average week.Search Interest14 people have searched for GEVO on MarketBeat in the last 30 days. This is an increase of 56% compared to the previous 30 days.MarketBeat Follows4 people have added Gevo to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Gevo insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.00% of the stock of Gevo is held by insiders.Percentage Held by InstitutionsOnly 35.17% of the stock of Gevo is held by institutions.Read more about Gevo's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Gevo are expected to grow in the coming year, from ($0.34) to ($0.32) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Gevo is -2.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Gevo is -2.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioGevo has a P/B Ratio of 0.26. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Gevo's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About Gevo Stock (NASDAQ:GEVO)Gevo, Inc. operates as a carbon abatement company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company focuses on transforming renewable energy into energy-dense liquid hydrocarbons that can be used as renewable fuels. It offers renewable gasoline and diesel, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006. Gevo, Inc. was incorporated in 2005 and is headquartered in Englewood, Colorado.Read More GEVO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GEVO Stock News HeadlinesJuly 24 at 1:01 PM | msn.comGevo wants state exemption for different power sourceJuly 23 at 9:54 PM | morningstar.comGevo Inc GEVOJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.July 21, 2024 | investorplace.com7 Energy Stocks to Buy as Americans Prioritize Travel More Than EverJuly 17, 2024 | globenewswire.comGevo to Report Second Quarter 2024 Financial Results on August 8, 2024July 15, 2024 | insidermonkey.comIs Gevo, Inc. (GEVO) Among the Best Penny Stocks to Buy Under $1 Right Now?July 15, 2024 | globenewswire.comGevo Provides Renewable Natural Gas Production UpdateJune 19, 2024 | investorplace.comFrom Pennies to Paydays: 3 Stocks Set to Skyrocket in 5 YearsJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.May 28, 2024 | bbc.co.ukFarage blames 'short notice' after ruling out MP bidMay 28, 2024 | finance.yahoo.comSustainable Aviation Fuel Market Report 2024 - Global SAF On Course to Surpass US$ 1.46 Billion in 2024May 17, 2024 | msn.comRSI Oversold Indicator Points to Possible Upside for Gevo (GEVO) StockMay 16, 2024 | msn.comThe South Dakota hometown of Laura Ingalls Wilder is set for a growth spurtMay 14, 2024 | globenewswire.comGevo President and Chief Operating Officer, Dr. Chris Ryan, to Participate in Virtual Investor MeetingMay 7, 2024 | finance.yahoo.comGevo’s Verity and ClearFlame Announce Transportation Decarbonization CollaborationMay 7, 2024 | globenewswire.comGevo's Verity and ClearFlame Announce Transportation Decarbonization CollaborationMay 6, 2024 | yahoo.comCompany behind proposed South Dakota jet fuel plant buoyed by federal carbon credit rulingMay 4, 2024 | finance.yahoo.comGevo, Inc. (NASDAQ:GEVO) Just Reported And Analysts Have Been Cutting Their EstimatesSee More Headlines Receive GEVO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Gevo and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/02/2024Today7/26/2024Next Earnings (Confirmed)8/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorOils/Energy Industry Industrial organic chemicals Sub-IndustryOil & Gas Refining & Marketing Current SymbolNASDAQ:GEVO CUSIP37439610 CIK1392380 Webwww.gevo.com Phone(303) 858-8358FaxN/AEmployees100Year Founded2005Price Target and Rating Average Stock Price Target$4.76 High Stock Price Target$14.00 Low Stock Price Target$0.85 Potential Upside/Downside+674.3%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.29) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-66,210,000.00 Net Margins-393.88% Pretax Margin-393.88% Return on Equity-11.97% Return on Assets-10.27% Debt Debt-to-Equity Ratio0.13 Current Ratio12.80 Quick Ratio12.62 Sales & Book Value Annual Sales$17.20 million Price / Sales8.45 Cash FlowN/A Price / Cash FlowN/A Book Value$2.32 per share Price / Book0.27Miscellaneous Outstanding Shares236,230,000Free Float226,784,000Market Cap$145.31 million OptionableOptionable Beta2.90 Social Links 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesDr. Patrick R. Gruber M.B.A. (Age 63)Ph.D., CEO & Director Comp: $1.5MDr. Christopher M. Ryan Ph.D. (Age 63)President & COO Comp: $844.61kMr. L. Lynn Smull (Age 63)Chief Financial Officer Comp: $708.78kMs. Kimberly T. Bowron SPHR (Age 53)Chief People Officer Comp: $552.84kDr. Paul D. Bloom (Age 50)Chief Carbon Officer & Chief Innovation Officer Comp: $744.38kProf. James C. Liao Ph.D.Co-FounderMr. Alisher Nurmat CPA (Age 54)VP of Accounting, Principal Accounting Officer & Treasurer Ms. Heather L. ManuelVice President of Corporate CommunicationsMr. Andrew L. Shafer (Age 62)Chief Marketing, Customer & Brand Officer Mr. David A. GeorgeSenior Vice President of Verity TrackingMore ExecutivesKey CompetitorsAlto IngredientsNASDAQ:PEIXAmyrisNASDAQ:AMRSGreen Plains PartnersNASDAQ:GPPPhillips 66NYSE:PSXMarathon PetroleumNYSE:MPCView All CompetitorsInsiders & InstitutionsPaloma Partners Management CoBought 95,900 shares on 5/16/2024Ownership: 0.041%Bayesian Capital Management LPBought 35,352 shares on 5/16/2024Ownership: 0.015%Price T Rowe Associates Inc. MDBought 192,457 shares on 5/15/2024Ownership: 0.145%Healthcare of Ontario Pension Plan Trust FundSold 197,106 shares on 5/14/2024Ownership: 0.076%Vanguard Group Inc.Bought 409,693 shares on 5/10/2024Ownership: 5.844%View All Insider TransactionsView All Institutional Transactions GEVO Stock Analysis - Frequently Asked Questions How have GEVO shares performed this year? Gevo's stock was trading at $1.16 on January 1st, 2024. Since then, GEVO stock has decreased by 47.7% and is now trading at $0.6062. View the best growth stocks for 2024 here. How were Gevo's earnings last quarter? Gevo, Inc. (NASDAQ:GEVO) released its quarterly earnings results on Thursday, May, 2nd. The energy company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.06) by $0.02. The energy company had revenue of $3.99 million for the quarter, compared to analysts' expectations of $4.39 million. Gevo had a negative net margin of 393.88% and a negative trailing twelve-month return on equity of 11.97%. When did Gevo's stock split? Gevo shares reverse split before market open on Monday, June 4th 2018. The 1-20 reverse split was announced on Friday, June 1st 2018. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 1st 2018. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What is Patrick Gruber's approval rating as Gevo's CEO? 7 employees have rated Gevo Chief Executive Officer Patrick Gruber on Glassdoor.com. Patrick Gruber has an approval rating of 15% among the company's employees. This puts Patrick Gruber in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. How do I buy shares of Gevo? Shares of GEVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Gevo own? Based on aggregate information from My MarketBeat watchlists, some other companies that Gevo investors own include Bionano Genomics (BNGO), Heat Biologics (HTBX), Sorrento Therapeutics (SRNE), Aeterna Zentaris (AEZS), Zosano Pharma (ZSAN), ADMA Biologics (ADMA) and Matinas BioPharma (MTNB). This page (NASDAQ:GEVO) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gevo, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gevo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.